Fusion event
HBV-chrY integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAA| |GATCTACAGCATGGGGCAGAATCTTTCCACCAGCAATCCTCTGGGATTCTTTCCCGACCACCAGTTGGATCCAGCCTTCAGAGCAAACACCGCAAATCCA
End
58845159/56745710 (Hg38)
Nearest miRNA
hsa-mir-12120/Upstream/43266444;
Upstream sequence
ttcattcgactccattatattcaattccattccactcgaatccattccattagaggacattccattccaatgcattccattccattccatagcattccat
Downstream sequence
cattcagtttgattccattccgtgaaatttcgttccattctattccattgcattactttccattcaattccattccatttcatttcagtccattcgcttc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.